LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Plus Therapeutics (NASDAQ: PSTV)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ PSTV Plus Therapeutics
Sims Andrew John Hugh MacIntyre / officer: Chief Financial Officer
11/04/2025
Buy
$0.51
20,000
$10K
68,138